Tracheal agenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3346Q32.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tracheal agenesis (also known as tracheal atresia or congenital absence of the trachea) is an extremely rare and usually fatal congenital malformation characterized by the complete or near-complete absence of the trachea (windpipe). This condition affects the respiratory system and is incompatible with normal breathing at birth. The trachea, which normally connects the larynx to the bronchi and lungs, fails to develop properly during embryonic life, resulting in a severe airway obstruction that presents immediately at birth. Affected neonates typically present with severe respiratory distress at birth, absence of audible cry, and inability to be intubated through conventional orotracheal methods. Cyanosis develops rapidly. In some cases, a tracheoesophageal fistula may be present, which can provide a temporary and limited airway connection through the esophagus to the bronchi, briefly sustaining some gas exchange. Tracheal agenesis is classified into three anatomical types (Floyd types I, II, and III) based on the extent of tracheal absence and the relationship between the bronchi and esophagus. Type II, in which the trachea is completely absent and the main bronchi arise from the esophagus via a common fistula, is the most common subtype. Associated congenital anomalies are frequent and may include cardiovascular malformations, genitourinary anomalies, gastrointestinal defects, and skeletal abnormalities. Some cases occur as part of broader associations or syndromes. The prognosis is extremely poor, with the vast majority of affected infants dying shortly after birth despite emergency interventions. Emergency management may include esophageal intubation to ventilate through a tracheoesophageal fistula if present. Surgical reconstruction or tracheal replacement strategies have been attempted in rare cases, but long-term survival remains exceptionally rare. There is currently no established curative treatment, and management is largely supportive and palliative.

Also known as:

Clinical phenotype terms— hover any for plain English:

Tracheal atresiaHP:0100682
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tracheal agenesis.

View clinical trials →

No actively recruiting trials found for Tracheal agenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tracheal agenesis community →

No specialists are currently listed for Tracheal agenesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tracheal agenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tracheal agenesisForum →

No community posts yet. Be the first to share your experience with Tracheal agenesis.

Start the conversation →

Latest news about Tracheal agenesis

No recent news articles for Tracheal agenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tracheal agenesis

What is Tracheal agenesis?

Tracheal agenesis (also known as tracheal atresia or congenital absence of the trachea) is an extremely rare and usually fatal congenital malformation characterized by the complete or near-complete absence of the trachea (windpipe). This condition affects the respiratory system and is incompatible with normal breathing at birth. The trachea, which normally connects the larynx to the bronchi and lungs, fails to develop properly during embryonic life, resulting in a severe airway obstruction that presents immediately at birth. Affected neonates typically present with severe respiratory distress

How is Tracheal agenesis inherited?

Tracheal agenesis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tracheal agenesis typically begin?

Typical onset of Tracheal agenesis is neonatal. Age of onset can vary across affected individuals.